Navigation Links
SNM releases new fact sheet on breast cancer and molecular imaging
Date:10/3/2008

RESTON, Va.Coinciding with the observance of Nuclear Medicine Week (October 5 to 11) and National Breast Cancer Awareness Month (October), SNM released today a new fact sheet highlighting recent developments in molecular imaging technologies that are dramatically improving the ways in which breast cancer is diagnosed and treated.

Molecular imaging is a highly effective, safe and painless imaging tool for diagnosing and treating breast cancer. Physicians report that the information they have gained from molecular imaging technologies has resulted in decisions to change the course of treatment in between 24 and 48 percent of breast cancer cases.

Breast cancer is just one of many types of cancer for which new and emerging molecular imaging techniques and therapies can significantly improve detection, diagnosis and treatment.

"As a field, molecular imaging is evolving very rapidly," said SNM President Robert W. Atcher, Ph.D., M.B.A. "Each new discoverywhether through improved cancer diagnosis and treatment, increased understanding of the fundamental causes of Alzheimer's disease or strides in how we treat cardiovascular diseasebrings personalized medicine one step closer to reality. Molecular imaging techniques and therapies allow us to understand what is happening at a cellular level. Physicians can actually see the precise location of disease, determine if other organs are being affected and then target treatment. It is about delivering the right treatment to the right patient at the right time."

Molecular imaging has the power to:

  • Diagnose cancer early onat its most curable stage;
  • Create a portrait of what cells are doing and how they function over time;
  • Eliminate the need for unnecessary exploratory surgery or multiple surgeries;
  • Provide a painless and cost-effective alternative to more expensiveand less accuratediagnostic tests;
  • Confirm and treat suspected recurrent cancers;
  • Monitor an individual's response to treatment and make adjustments as necessary;
  • Equip physicians and individuals with information to make informed decisions about the best courses of action.

"Molecular imaging has the ability to detect abnormalities very early in the progression of disease, or even before symptoms occurpotentially saving countless lives," added Atcher. "Working together with patients and their caregivers, we can truly imagine the future."


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related biology news :

1. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
2. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
3. EPA releases report on climate change and health
4. EPA releases science assessment on health effects of nitrogen oxides
5. Pioneering landscape-scale research releases first findings
6. Wildlife Conservation Society releases definitive state of the wild
7. DOE JGI releases a new version of its metagenome data management and analysis system
8. DOE JGI releases soybean genome assembly to enable worldwide bioenergy research efforts
9. WHRC releases 4 key reports
10. University of Minnesota releases first ever comprehensive report of the health of college students
11. Toxic releases down from North American industry leaders, increasing from other facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... to enabling healthier lives through the development of innovative ... of the United States denied ... that the claims of Sequenom,s U.S. Patent No. 6,258,540 ... eligibility criteria established by the Supreme Court,s Mayo Collaborative ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
Breaking Biology Technology: